Emergence of small interfering RNA-based gene drugs for various diseases
H Kurakula, S Vaishnavi, MY Sharif, S Ellipilli - ACS omega, 2023 - ACS Publications
Small molecule, peptide, and protein-based drugs have been developed over decades to
treat various diseases. The importance of gene therapy as an alternative to traditional drugs …
treat various diseases. The importance of gene therapy as an alternative to traditional drugs …
[HTML][HTML] RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations
CS Nabzdyk, L Pradhan-Nabzdyk… - Journal of Translational …, 2017 - Springer
Background Cardiovascular disease remains a major health care challenge. The knowledge
about the underlying mechanisms of the respective vascular disease etiologies has greatly …
about the underlying mechanisms of the respective vascular disease etiologies has greatly …
RNA therapeutics in cardiovascular disease
T Lucas, A Bonauer, S Dimmeler - Circulation research, 2018 - Am Heart Assoc
Noncoding RNAs have been shown to exert important physiological and pathophysiological
functions. Various studies suggest that modulating noncoding RNAs may provide a …
functions. Various studies suggest that modulating noncoding RNAs may provide a …
Long non-coding RNA therapeutics: recent advances and challenges
A Sangeeth, M Malleswarapu, A Mishra… - Current drug …, 2022 - ingentaconnect.com
The discovery of the roles of RNA other than just as a messenger, such as a ribozyme, and
regulatory RNAs, such as microRNA and long noncoding RNAs, is fascinating. RNA is now …
regulatory RNAs, such as microRNA and long noncoding RNAs, is fascinating. RNA is now …
Emerging drugs in the management of hypertension
JA Whitworth - Expert Opinion on Emerging Drugs, 2003 - Taylor & Francis
Hypertension is a global health problem, affecting developing and developed countries
alike. Most patients with hypertension are undiagnosed, and most diagnosed patients are …
alike. Most patients with hypertension are undiagnosed, and most diagnosed patients are …
Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes
MI Phillips, D Wielbo, R Gyurko - Kidney international, 1994 - Elsevier
Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genes.
There are several ways of experimentally studying the influence of candidate genes on …
There are several ways of experimentally studying the influence of candidate genes on …
[HTML][HTML] Updates in small interfering RNA for the treatment of dyslipidemias
S Carugo, CR Sirtori, G Gelpi, A Corsini… - Current Atherosclerosis …, 2023 - Springer
Abstract Purpose of Review Atherosclerotic cardiovascular disease (ASCVD) is still the
leading cause of death worldwide. Despite excellent pharmacological approaches, clinical …
leading cause of death worldwide. Despite excellent pharmacological approaches, clinical …
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
Hypertension is a diverse illness interlinked with cerebral, cardiovascular (CVS) and renal
abnormalities. Presently, the malady is being treated by focusing on Renin-angiotensin …
abnormalities. Presently, the malady is being treated by focusing on Renin-angiotensin …
[HTML][HTML] RNA-based therapy in the management of lipid disorders: a review
DJ Blom, AD Marais, R Moodley… - Lipids in Health and …, 2022 - Springer
This review focuses on antisense oligonucleotides and small interfering ribonucleic acid
therapies approved or under development for the management of lipid disorders. Recent …
therapies approved or under development for the management of lipid disorders. Recent …
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
The era of RNA medicine has become a reality with the success of messenger RNA (mRNA)
vaccines against COVID-19 and the approval of several RNA interference (RNAi) agents in …
vaccines against COVID-19 and the approval of several RNA interference (RNAi) agents in …